Clinical Trial Update: Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fluocinonide cream 0.1% for reducing itch in subjects with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Fluocinonide Cream 0.1% (Vanos(R)) (fluocinonide)

Snippet

Sponsor: Wake Forest University | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2017-05-01